Cutler Group LP Pa Vmed Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.22 - $0.5 $132 - $300	-600 Reduced 31.28%	1,318 $0
Q1 2023 May 01, 2023	SELL	$0.36 - $0.63 $572 - $1,002	-1,591 Reduced 45.34%	1,918 $0
Q3 2022 Oct 25, 2022	BUY	$0.57 - $1.77 $56 - $177	100 Added 2.93%	3,509 $3,000
Q2 2022 Aug 04, 2022	SELL	$0.85 - $1.41 $2,550 - $4,230	-3,000 Reduced 46.81%	3,409 $3,000
Q1 2022 Apr 14, 2022	BUY	$1.16 - $2.5 $4,872 - $10,500	4,200 Added 190.13%	6,409 $8,000

Q4 2021 Jan 18, 2022	BUY	$2.46 - $8.74 $3,229 - $11,475	1,313 Added 146.54%	2,209 $5,000
Q2 2021 Jul 19, 2021	BUY	$3.95 - $6.88 $3,539 - $6,164	896 New	896 $5,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $74.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.